APO Research
Talk to an analyst

APO RESEARCH · REPORT

Budesonide Inhaler

Compare research editions
View pricing & licenses

Selected research

Industry Research

Budesonide Inhaler Industry Research Report 2026

22 December 2025136 pages

Choose your research edition.

Industry ResearchBudesonide Inhaler Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide Inhaler Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Budesonide Inhaler Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide Inhaler Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide Inhaler Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Budesonide Inhaler market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Budesonide Inhaler is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Budesonide Inhaler is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Budesonide Inhaler is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Budesonide Inhaler include Shanghai Sine Pharmaceutical Laboratories, Takeda Pharmaceutical, Teva Pharmaceutical, Novartis, Mylan, Lunan Better Pharmaceutical, Pfizer, AstraZeneca and Synmosa Biopharma Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Budesonide Inhaler market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Budesonide Inhaler Market by Company

Shanghai Sine Pharmaceutical Laboratories

Takeda Pharmaceutical

Teva Pharmaceutical

Novartis

Mylan

Lunan Better Pharmaceutical

Pfizer

AstraZeneca

Synmosa Biopharma Corporation

Orion Corporation

Lupin Limited

Dr. Falk Pharma

Cosmo Pharmaceuticals

Cipla Limited

Chiesi Farmaceutici

Bausch Health Companies

Budesonide Inhaler Segment by Type

Dry Powder

Sprays

Suspension

Budesonide Inhaler Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Budesonide Inhaler Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide Inhaler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide Inhaler and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide Inhaler.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Budesonide Inhaler manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Budesonide Inhaler by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Budesonide Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Budesonide Inhaler Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Budesonide Inhaler Sales (k units) of Manufacturers (2021-2026) Table 7. Global Budesonide Inhaler Sales Market Share by Manufacturers (2021-2026) Table 8. Global Budesonide Inhaler Revenue of Manufacturers (2021-2026) Table 9. Global Budesonide Inhaler Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Budesonide Inhaler Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Budesonide Inhaler Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Budesonide Inhaler, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Budesonide Inhaler, Product Type & Application Table 14. Global Budesonide Inhaler Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Budesonide Inhaler by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Shanghai Sine Pharmaceutical Laboratories Company Information Table 19. Shanghai Sine Pharmaceutical Laboratories Business Overview Table 20. Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Product Portfolio Table 22. Shanghai Sine Pharmaceutical Laboratories Recent Developments Table 23. Takeda Pharmaceutical Company Information Table 24. Takeda Pharmaceutical Business Overview Table 25. Takeda Pharmaceutical Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Takeda Pharmaceutical Budesonide Inhaler Product Portfolio Table 27. Takeda Pharmaceutical Recent Developments Table 28. Teva Pharmaceutical Company Information Table 29. Teva Pharmaceutical Business Overview Table 30. Teva Pharmaceutical Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Teva Pharmaceutical Budesonide Inhaler Product Portfolio Table 32. Teva Pharmaceutical Recent Developments Table 33. Novartis Company Information Table 34. Novartis Business Overview Table 35. Novartis Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Novartis Budesonide Inhaler Product Portfolio Table 37. Novartis Recent Developments Table 38. Mylan Company Information Table 39. Mylan Business Overview Table 40. Mylan Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Mylan Budesonide Inhaler Product Portfolio Table 42. Mylan Recent Developments Table 43. Lunan Better Pharmaceutical Company Information Table 44. Lunan Better Pharmaceutical Business Overview Table 45. Lunan Better Pharmaceutical Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Lunan Better Pharmaceutical Budesonide Inhaler Product Portfolio Table 47. Lunan Better Pharmaceutical Recent Developments Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Pfizer Budesonide Inhaler Product Portfolio Table 52. Pfizer Recent Developments Table 53. AstraZeneca Company Information Table 54. AstraZeneca Business Overview Table 55. AstraZeneca Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. AstraZeneca Budesonide Inhaler Product Portfolio Table 57. AstraZeneca Recent Developments Table 58. Synmosa Biopharma Corporation Company Information Table 59. Synmosa Biopharma Corporation Business Overview Table 60. Synmosa Biopharma Corporation Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Synmosa Biopharma Corporation Budesonide Inhaler Product Portfolio Table 62. Synmosa Biopharma Corporation Recent Developments Table 63. Orion Corporation Company Information Table 64. Orion Corporation Business Overview Table 65. Orion Corporation Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Orion Corporation Budesonide Inhaler Product Portfolio Table 67. Orion Corporation Recent Developments Table 68. Lupin Limited Company Information Table 69. Lupin Limited Business Overview Table 70. Lupin Limited Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Lupin Limited Budesonide Inhaler Product Portfolio Table 72. Lupin Limited Recent Developments Table 73. Dr. Falk Pharma Company Information Table 74. Dr. Falk Pharma Business Overview Table 75. Dr. Falk Pharma Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Dr. Falk Pharma Budesonide Inhaler Product Portfolio Table 77. Dr. Falk Pharma Recent Developments Table 78. Cosmo Pharmaceuticals Company Information Table 79. Cosmo Pharmaceuticals Business Overview Table 80. Cosmo Pharmaceuticals Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Cosmo Pharmaceuticals Budesonide Inhaler Product Portfolio Table 82. Cosmo Pharmaceuticals Recent Developments Table 83. Cipla Limited Company Information Table 84. Cipla Limited Business Overview Table 85. Cipla Limited Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Cipla Limited Budesonide Inhaler Product Portfolio Table 87. Cipla Limited Recent Developments Table 88. Chiesi Farmaceutici Company Information Table 89. Chiesi Farmaceutici Business Overview Table 90. Chiesi Farmaceutici Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Chiesi Farmaceutici Budesonide Inhaler Product Portfolio Table 92. Chiesi Farmaceutici Recent Developments Table 93. Bausch Health Companies Company Information Table 94. Bausch Health Companies Business Overview Table 95. Bausch Health Companies Budesonide Inhaler Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Bausch Health Companies Budesonide Inhaler Product Portfolio Table 97. Bausch Health Companies Recent Developments Table 98. Global Budesonide Inhaler Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Budesonide Inhaler Sales by Region (2021-2026) & (k units) Table 100. Global Budesonide Inhaler Sales Market Share by Region (2021-2026) Table 101. Global Budesonide Inhaler Sales by Region (2027-2032) & (k units) Table 102. Global Budesonide Inhaler Sales Market Share by Region (2027-2032) Table 103. Global Budesonide Inhaler Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Budesonide Inhaler Revenue Market Share by Region (2021-2026) Table 105. Global Budesonide Inhaler Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Budesonide Inhaler Revenue Market Share by Region (2027-2032) Table 107. North America Budesonide Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Budesonide Inhaler Sales by Country (2021-2026) & (k units) Table 109. North America Budesonide Inhaler Sales by Country (2027-2032) & (k units) Table 110. North America Budesonide Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Budesonide Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Budesonide Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Budesonide Inhaler Sales by Country (2021-2026) & (k units) Table 114. Europe Budesonide Inhaler Sales by Country (2027-2032) & (k units) Table 115. Europe Budesonide Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Budesonide Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Budesonide Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Budesonide Inhaler Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Budesonide Inhaler Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Budesonide Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Budesonide Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Budesonide Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Budesonide Inhaler Sales by Country (2021-2026) & (k units) Table 124. South America Budesonide Inhaler Sales by Country (2027-2032) & (k units) Table 125. South America Budesonide Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Budesonide Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Budesonide Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Budesonide Inhaler Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Budesonide Inhaler Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Budesonide Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Budesonide Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Budesonide Inhaler Sales by Type (2021-2026) & (k units) Table 133. Global Budesonide Inhaler Sales by Type (2027-2032) & (k units) Table 134. Global Budesonide Inhaler Sales Market Share by Type (2021-2026) Table 135. Global Budesonide Inhaler Sales Market Share by Type (2027-2032) Table 136. Global Budesonide Inhaler Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Budesonide Inhaler Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Budesonide Inhaler Revenue Market Share by Type (2021-2026) Table 139. Global Budesonide Inhaler Revenue Market Share by Type (2027-2032) Table 140. Global Budesonide Inhaler Price by Type (2021-2026) & (US$/unit) Table 141. Global Budesonide Inhaler Price by Type (2027-2032) & (US$/unit) Table 142. Global Budesonide Inhaler Sales by Application (2021-2026) & (k units) Table 143. Global Budesonide Inhaler Sales by Application (2027-2032) & (k units) Table 144. Global Budesonide Inhaler Sales Market Share by Application (2021-2026) Table 145. Global Budesonide Inhaler Sales Market Share by Application (2027-2032) Table 146. Global Budesonide Inhaler Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Budesonide Inhaler Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Budesonide Inhaler Revenue Market Share by Application (2021-2026) Table 149. Global Budesonide Inhaler Revenue Market Share by Application (2027-2032) Table 150. Global Budesonide Inhaler Price by Application (2021-2026) & (US$/unit) Table 151. Global Budesonide Inhaler Price by Application (2027-2032) & (US$/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Budesonide Inhaler Distributors List Table 155. Budesonide Inhaler Customers List Table 156. Budesonide Inhaler Industry Trends Table 157. Budesonide Inhaler Industry Drivers Table 158. Budesonide Inhaler Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Budesonide Inhaler Product Image Figure 5. Global Budesonide Inhaler Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Budesonide Inhaler Market Size (2021-2032) & (US$ Million) Figure 7. Global Budesonide Inhaler Sales (2021-2032) & (k units) Figure 8. Global Budesonide Inhaler Average Price (US$/unit) & (2021-2032) Figure 9. Dry Powder Product Image Figure 10. Sprays Product Image Figure 11. Suspension Product Image Figure 12. Hospital Pharmacies Product Image Figure 13. Online Pharmacies Product Image Figure 14. Retail Pharmacies Product Image Figure 15. Global Budesonide Inhaler Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Budesonide Inhaler, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Budesonide Inhaler Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Budesonide Inhaler Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Budesonide Inhaler Sales by Region in 2025 Figure 21. Global Budesonide Inhaler Revenue by Region in 2025 Figure 22. North America Budesonide Inhaler Market Size by Country in 2025 Figure 23. North America Budesonide Inhaler Sales Market Share by Country (2021-2032) Figure 24. North America Budesonide Inhaler Revenue Market Share by Country (2021-2032) Figure 25. United States Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Budesonide Inhaler Market Size by Country in 2025 Figure 29. Europe Budesonide Inhaler Sales Market Share by Country (2021-2032) Figure 30. Europe Budesonide Inhaler Revenue Market Share by Country (2021-2032) Figure 31. Germany Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Budesonide Inhaler Market Size by Country in 2025 Figure 42. Asia Pacific Budesonide Inhaler Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Budesonide Inhaler Revenue Market Share by Country (2021-2032) Figure 44. China Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Budesonide Inhaler Market Size by Country in 2025 Figure 53. South America Budesonide Inhaler Sales Market Share by Country (2021-2032) Figure 54. South America Budesonide Inhaler Revenue Market Share by Country (2021-2032) Figure 55. Brazil Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Budesonide Inhaler Market Size by Country in 2025 Figure 59. Middle East and Africa Budesonide Inhaler Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Budesonide Inhaler Revenue Market Share by Country (2021-2032) Figure 61. Egypt Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Budesonide Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Budesonide Inhaler Sales Market Share by Type (2021-2032) Figure 67. Global Budesonide Inhaler Revenue Market Share by Type (2021-2032) Figure 68. Global Budesonide Inhaler Price (US$/unit) by Type (2021-2032) Figure 69. Global Budesonide Inhaler Sales Market Share by Application (2021-2032) Figure 70. Global Budesonide Inhaler Revenue Market Share by Application (2021-2032) Figure 71. Global Budesonide Inhaler Price (US$/unit) by Application (2021-2032) Figure 72. Budesonide Inhaler Value Chain Figure 73. Budesonide Inhaler Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Budesonide Inhaler Industry Opportunities and Challenges

Scope & coverage.

Types
  • Dry Powder
  • Sprays
  • Suspension
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Shanghai Sine Pharmaceutical Laboratories
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • Novartis
  • Mylan
  • Lunan Better Pharmaceutical
  • Pfizer
  • AstraZeneca
  • Synmosa Biopharma Corporation
  • Orion Corporation
  • Lupin Limited
  • Dr. Falk Pharma
  • Cosmo Pharmaceuticals
  • Cipla Limited
  • Chiesi Farmaceutici
  • Bausch Health Companies

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Budesonide Inhaler Market Size (2021-2032)
  4. 2.2.2 Global Budesonide Inhaler Sales (2021-2032)
  5. 2.2.3 Global Budesonide Inhaler Market Average Price (2021-2032)
  6. 2.3 Budesonide Inhaler by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Dry Powder
  9. 2.3.3 Sprays
  10. 2.3.4 Suspension
  11. 2.4 Budesonide Inhaler by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital Pharmacies
  14. 2.4.3 Online Pharmacies
  15. 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Budesonide Inhaler Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Budesonide Inhaler Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Budesonide Inhaler Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Budesonide Inhaler Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Budesonide Inhaler Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Budesonide Inhaler, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Budesonide Inhaler, Product Type & Application
  8. 3.8 Global Manufacturers of Budesonide Inhaler, Established Date
  9. 3.9 Global Budesonide Inhaler Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Shanghai Sine Pharmaceutical Laboratories
  2. 4.1.1 Shanghai Sine Pharmaceutical Laboratories Company Information
  3. 4.1.2 Shanghai Sine Pharmaceutical Laboratories Business Overview
  4. 4.1.3 Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Product Portfolio
  6. 4.1.5 Shanghai Sine Pharmaceutical Laboratories Recent Developments
  7. 4.2 Takeda Pharmaceutical
  8. 4.2.1 Takeda Pharmaceutical Company Information
  9. 4.2.2 Takeda Pharmaceutical Business Overview
  10. 4.2.3 Takeda Pharmaceutical Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Takeda Pharmaceutical Budesonide Inhaler Product Portfolio
  12. 4.2.5 Takeda Pharmaceutical Recent Developments
  13. 4.3 Teva Pharmaceutical
  14. 4.3.1 Teva Pharmaceutical Company Information
  15. 4.3.2 Teva Pharmaceutical Business Overview
  16. 4.3.3 Teva Pharmaceutical Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Teva Pharmaceutical Budesonide Inhaler Product Portfolio
  18. 4.3.5 Teva Pharmaceutical Recent Developments
  19. 4.4 Novartis
  20. 4.4.1 Novartis Company Information
  21. 4.4.2 Novartis Business Overview
  22. 4.4.3 Novartis Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novartis Budesonide Inhaler Product Portfolio
  24. 4.4.5 Novartis Recent Developments
  25. 4.5 Mylan
  26. 4.5.1 Mylan Company Information
  27. 4.5.2 Mylan Business Overview
  28. 4.5.3 Mylan Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Mylan Budesonide Inhaler Product Portfolio
  30. 4.5.5 Mylan Recent Developments
  31. 4.6 Lunan Better Pharmaceutical
  32. 4.6.1 Lunan Better Pharmaceutical Company Information
  33. 4.6.2 Lunan Better Pharmaceutical Business Overview
  34. 4.6.3 Lunan Better Pharmaceutical Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Lunan Better Pharmaceutical Budesonide Inhaler Product Portfolio
  36. 4.6.5 Lunan Better Pharmaceutical Recent Developments
  37. 4.7 Pfizer
  38. 4.7.1 Pfizer Company Information
  39. 4.7.2 Pfizer Business Overview
  40. 4.7.3 Pfizer Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Budesonide Inhaler Product Portfolio
  42. 4.7.5 Pfizer Recent Developments
  43. 4.8 AstraZeneca
  44. 4.8.1 AstraZeneca Company Information
  45. 4.8.2 AstraZeneca Business Overview
  46. 4.8.3 AstraZeneca Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 AstraZeneca Budesonide Inhaler Product Portfolio
  48. 4.8.5 AstraZeneca Recent Developments
  49. 4.9 Synmosa Biopharma Corporation
  50. 4.9.1 Synmosa Biopharma Corporation Company Information
  51. 4.9.2 Synmosa Biopharma Corporation Business Overview
  52. 4.9.3 Synmosa Biopharma Corporation Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Synmosa Biopharma Corporation Budesonide Inhaler Product Portfolio
  54. 4.9.5 Synmosa Biopharma Corporation Recent Developments
  55. 4.10 Orion Corporation
  56. 4.10.1 Orion Corporation Company Information
  57. 4.10.2 Orion Corporation Business Overview
  58. 4.10.3 Orion Corporation Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Orion Corporation Budesonide Inhaler Product Portfolio
  60. 4.10.5 Orion Corporation Recent Developments
  61. 4.11 Lupin Limited
  62. 4.11.1 Lupin Limited Company Information
  63. 4.11.2 Lupin Limited Business Overview
  64. 4.11.3 Lupin Limited Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Lupin Limited Budesonide Inhaler Product Portfolio
  66. 4.11.5 Lupin Limited Recent Developments
  67. 4.12 Dr. Falk Pharma
  68. 4.12.1 Dr. Falk Pharma Company Information
  69. 4.12.2 Dr. Falk Pharma Business Overview
  70. 4.12.3 Dr. Falk Pharma Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dr. Falk Pharma Budesonide Inhaler Product Portfolio
  72. 4.12.5 Dr. Falk Pharma Recent Developments
  73. 4.13 Cosmo Pharmaceuticals
  74. 4.13.1 Cosmo Pharmaceuticals Company Information
  75. 4.13.2 Cosmo Pharmaceuticals Business Overview
  76. 4.13.3 Cosmo Pharmaceuticals Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Cosmo Pharmaceuticals Budesonide Inhaler Product Portfolio
  78. 4.13.5 Cosmo Pharmaceuticals Recent Developments
  79. 4.14 Cipla Limited
  80. 4.14.1 Cipla Limited Company Information
  81. 4.14.2 Cipla Limited Business Overview
  82. 4.14.3 Cipla Limited Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Cipla Limited Budesonide Inhaler Product Portfolio
  84. 4.14.5 Cipla Limited Recent Developments
  85. 4.15 Chiesi Farmaceutici
  86. 4.15.1 Chiesi Farmaceutici Company Information
  87. 4.15.2 Chiesi Farmaceutici Business Overview
  88. 4.15.3 Chiesi Farmaceutici Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Chiesi Farmaceutici Budesonide Inhaler Product Portfolio
  90. 4.15.5 Chiesi Farmaceutici Recent Developments
  91. 4.16 Bausch Health Companies
  92. 4.16.1 Bausch Health Companies Company Information
  93. 4.16.2 Bausch Health Companies Business Overview
  94. 4.16.3 Bausch Health Companies Budesonide Inhaler Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Bausch Health Companies Budesonide Inhaler Product Portfolio
  96. 4.16.5 Bausch Health Companies Recent Developments
5 Global Budesonide Inhaler Market Scenario by Region
  1. 5.1 Global Budesonide Inhaler Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Budesonide Inhaler Sales by Region: 2021-2032
  3. 5.2.1 Global Budesonide Inhaler Sales by Region: 2021-2026
  4. 5.2.2 Global Budesonide Inhaler Sales by Region: 2027-2032
  5. 5.3 Global Budesonide Inhaler Revenue by Region: 2021-2032
  6. 5.3.1 Global Budesonide Inhaler Revenue by Region: 2021-2026
  7. 5.3.2 Global Budesonide Inhaler Revenue by Region: 2027-2032
  8. 5.4 North America Budesonide Inhaler Market Facts & Figures by Country
  9. 5.4.1 North America Budesonide Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Budesonide Inhaler Sales by Country (2021-2032)
  11. 5.4.3 North America Budesonide Inhaler Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Budesonide Inhaler Market Facts & Figures by Country
  16. 5.5.1 Europe Budesonide Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Budesonide Inhaler Sales by Country (2021-2032)
  18. 5.5.3 Europe Budesonide Inhaler Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Budesonide Inhaler Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Budesonide Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Budesonide Inhaler Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Budesonide Inhaler Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Budesonide Inhaler Market Facts & Figures by Country
  41. 5.7.1 South America Budesonide Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Budesonide Inhaler Sales by Country (2021-2032)
  43. 5.7.3 South America Budesonide Inhaler Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Budesonide Inhaler Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Budesonide Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Budesonide Inhaler Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Budesonide Inhaler Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Budesonide Inhaler Sales by Type (2021-2032)
  2. 6.1.1 Global Budesonide Inhaler Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Budesonide Inhaler Sales Market Share by Type (2021-2032)
  4. 6.2 Global Budesonide Inhaler Revenue by Type (2021-2032)
  5. 6.2.1 Global Budesonide Inhaler Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Budesonide Inhaler Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Budesonide Inhaler Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Budesonide Inhaler Sales by Application (2021-2032)
  2. 7.1.1 Global Budesonide Inhaler Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Budesonide Inhaler Sales Market Share by Application (2021-2032)
  4. 7.2 Global Budesonide Inhaler Revenue by Application (2021-2032)
  5. 7.2.1 Global Budesonide Inhaler Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Budesonide Inhaler Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Budesonide Inhaler Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Budesonide Inhaler Value Chain Analysis
  2. 8.1.1 Budesonide Inhaler Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Budesonide Inhaler Production Mode & Process
  5. 8.2 Budesonide Inhaler Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Budesonide Inhaler Distributors
  8. 8.2.3 Budesonide Inhaler Customers
9 Global Budesonide Inhaler Analyzing Market Dynamics
  1. 9.1 Budesonide Inhaler Industry Trends
  2. 9.2 Budesonide Inhaler Industry Drivers
  3. 9.3 Budesonide Inhaler Industry Opportunities and Challenges
  4. 9.4 Budesonide Inhaler Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst